By Eneya Georgieva
The Bulgarian software company Sqilline opens two new offices – in Berlin and in Bucharest. Until now, its clients have mainly been Bulgarian organizations. Research also includes that foreign interest in Sqilline’s solutions is becoming more tangible and the company needs to look outside.
“Each hospital works with different data structures and one of the biggest challenges worldwide is how to bring these arrays of information into a form suitable for analysis. We have proven that we can find solutions in this area and thus Sqilline’s expansion comes completely natural”, said Desislava Mihaylova, co-founder and CEO of Sqilline – one of the founding members of the Digital Health and Innovation Cluster Bulgaria (DHI Cluster Bulgaria).
Sqilline outstands in the IT field with tailor-made technological solutions in the field of healthcare and pharmacy. The team is behind the development of the Danny Platform – the only leading analytical platform based on real data from oncology, cardiology and other diseases. Its activities are focused on processing information mainly from electronic health records at hospital level and the use of fast real-time summary analysis. In this way, the organizations that work with them can make decisions and strategies based on knowledge derived from real data from their practice.
This involves integrated machine self-learning algorithms and advanced tools for recent searches and analysis of disparate data for patients with different diagnoses, therapy, and specific clinical indicators. Another advantage of the Danny Platform is to analyze how specific factors affect patient interaction and to compare the effectiveness of different treatments with better results.
The Sqilline platform is used in advance by people who are not part of the technology sector. One of the advantages of the company is that the platform will be easy to use and will allow health experts to compare the analyzes created by in the same time contributing to science.
When creating academic work – scientific publications, developing therapies and tracking patient groups, our goal is to give doctors access to precision medicine through intuitive software. Thereby, they save lives and uptake knowledge in the sector to a whole new level.“ says Mihaylova.
Science is really important to Sqilline in order to develop a new approach towards dealing with rare problems. Typically, physicians who use the Danny Platform have access to information from their hospital profile. This helps them easily access data on previous cases and the treatment that has been most effective. However, what happens when an undiagnosed patient with a rare disease goes to a small clinic that does not have access to such a technological solution? “Our platform is like a ‘library’, offering search of similar cases according to symptoms and other patient complaints. If no match is found in the database of the respective hospital, most likely the patient will be given standard treatments and will be diagnosed later,” says Desislava Mihaylova. In this scenario, the National Single Platform for Rare Diseases has a chance to help improved patient care.
To support this process, Sqilline offers partnership projects involving several hospitals. Thus, the platform with technical data will be accessible to everyone and its size will be significantly larger. “Patient is always a priority and we encourage hospitals to share their knowledge. Thus, doctors in Germany can help a small clinic in Bulgaria by sharing their experience from similar cases as well as the most effective method for their treatment,” says Mihaylova.
Causes create strong partners
Over the past 12 years, Sqilline has proven to be a sustainable company and has easily weathered various macroeconomic crises. The company remained true to the cause of one-time good healthcare and in 2018 became a co-founder of the Digital Health and Innovation Cluster Bulgaria (DHI Cluster Bulgaria).
“We are united by our understanding of health problems and the belief that we can help solve them. The DHI Cluster Bulgaria consists of strong companies with an international presence and increasingly impressive discoveries. This proves that digitalisation of the sector is quite achievable. Maybe it will happen sooner than we think,” says Desislava Mihaylova.